SSH Communications Security Corporation
22.2.2021 12:01:38 CET | Globenewswire | Press release
SSH Communications Security Oyj - Managers' Transactions
SSH Communications Security Plc has today received the following notification:
Person subject to the notification requirement
Name: Österlund, Henri
Position: Member of the Board/Deputy member
Issuer: SSH Communications Security Oyj
LEI: 7437007N96FK4N3WHT09
Notification type: INITIAL NOTIFICATION
Reference number: 7437007N96FK4N3WHT09_20210222121116_2
____________________________________________
Transaction date: 2021-02-19
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: FI0009008270
Nature of the transaction: ACQUISITION
Transaction details
(1): Volume: 955 Unit price: 2.64 EUR
(2): Volume: 651 Unit price: 2.64 EUR
(3): Volume: 689 Unit price: 2.64 EUR
(4): Volume: 2,000 Unit price: 2.64 EUR
(5): Volume: 800 Unit price: 2.62 EUR
(6): Volume: 207 Unit price: 2.62 EUR
(7): Volume: 327 Unit price: 2.62 EUR
(8): Volume: 1,747 Unit price: 2.62 EUR
(9): Volume: 640 Unit price: 2.62 EUR
(10): Volume: 2,550 Unit price: 2.6 EUR
(11): Volume: 22 Unit price: 2.6 EUR
(12): Volume: 212 Unit price: 2.6 EUR
Aggregated transactions
(12): Volume: 10,800 Volume weighted average price: 2.6228 EUR
For further information, please contact:
Niklas Nordström, CFO, tel. +358 50 541 0543
Markku Karppi, General Counsel, tel. + 358 50 586 0552
Distribution:
Nasdaq Helsinki Ltd.
Major media
www.ssh.com
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
King Faisal Specialist Hospital & Research Centre13.3.2026 22:15:53 CET | Press release
KFSH Leads Globally in Paired Kidney Transplants Performed at a Single Center in 2025
SCOR13.3.2026 18:59:39 CET | Press release
SCOR SE announces the availability of its 2025 Universal Registration Document
Novartis Pharma AG13.3.2026 18:35:19 CET | Press release
Novartis Cosentyx® receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa
Luotea Oyj13.3.2026 18:30:00 CET | Press release
The Board of Directors of Luotea Oyj decided on updates to the company's share-based incentive plan for 2023-2027 and on the launch of a new share-based incentive plan for the years 2026-2030
Ilkka Oyj13.3.2026 18:00:00 CET | Press release
Ilkka Oyj: Acquisition of own shares on 13 March 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
